药物使用与常见癌症风险之间的关联:19种药物使用与常见癌症风险之间的关联:19种药物使用与常见癌症风险之间的关联:19种药物使用与常见癌症风险之间的关联:19种药物使用与常见癌症风险之间的关联:19种药物使用与常见癌症风险之间的关联:
Zhangjun Yun1,2, Yang Shen1, Xiang Yan1,2
1Department of Oncology and Haematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Journal of global health
|March 15, 2024
概括
针对宁-血管酶系统的药物显著降低前列腺癌的风险. 这一发现对心血管患者至关重要,影响药物选择和癌症预防策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 关于药物使用和癌症风险,存在不一致的发现.
- 一项大型研究调查了19种药物与四种常见癌症之间的因果关系.
研究的目的:
- 确定特定药物类别对癌症风险的因果关系.
- 为了研究氨酸 - 血管新生素系统药物与前列腺癌风险之间的关联.
主要方法:
- 横截面研究与倾向得分匹配和后勤回归.
- 使用全基因组关联研究数据进行双样本孟德尔随机化 (MR) 分析.
- 对灵敏度,复制,遗传相关性和反向MR分析进行了强度分析.
主要成果:
- 作用于氨酸- ангиотензин系统的药物显示前列腺癌的风险降低 (OR=0.42).
- 研究人员观察到,在使用氨酸-血管新生素系统药物和前列腺癌风险之间存在非线性关联.
- 核磁共振分析证实了对降低前列腺癌风险 (OR=0.94和OR=0.90) 的遗传责任对氨酸-血管新生素系统药物使用的因果关系.
结论:
- 用于氨酸 - ангиотензин系统作用的药物的使用与前列腺癌的风险降低有因果关系.
- 这些发现对前列腺癌预防和心血管疾病患者的药物选择有重大影响.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Hazard Ratio
120
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
120
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


